TORONTO, Nov. 12, 2018 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (“MediPharm Labs” or the “Company”) (TSXV: LABS) is pleased to announce that its wholly-owned subsidiary, MediPharm Labs Inc., has...
TORONTO, Nov. 08, 2018 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (the “Company” or “MediPharm Labs”) is pleased to announce that it has added two cannabis industry veterans...
TORONTO, Nov. 07, 2018 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (the “Company” or “MediPharm Labs”) is pleased to announce that it has reached a significant milestone by...
After extending upon September’s spectacular gains of 22.6% into mid-month and testing the highs from early 2018, the Canadian Cannabis LP Index sank 25.1% in October to 939.04: The index had run...
BARRIE, Ontario, Oct. 19, 2018 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (“MediPharm Labs” or the “Company”) (TSXV: LABS) continues to build momentum towards its goal of becoming a global...
TORONTO, Oct. 10, 2018 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (“MediPharm”) (TSXV: LABS) is pleased to announce that it has entered into a Cannabis Concentrate Program Agreement (the “Agreement”)...
